A 60-year-old man survived a life-threatening aortic arch aneurysm after timely diagnosis and minimally invasive TEVAR ...

A clinical discussion on how the long-term findings of the ZILVERPASS study inform decision-making for challenging ...

CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, today ...

Brainomix, an Oxford UK-based global leader and pioneer of AI-powered imaging tools in stroke and lung fibrosis, has unveiled ...

Additional funding will enhance Brainomix’s industry-leading customer support and fast-track product advancements across its Brainomix 360 Stroke and e-Lung AI imaging platforms. The extension round ...

Providence Sacred Heart Medical Center is being recognized as one of the nation's most advanced stroke care centers.

Dr. Koen Deloose describes his algorithmic approach to treating a patient with chronic limb-threatening ischemia and a nonhealing ulcer, with discussion from Drs. Katherine McMackin and Constantino ...

Brainomix, a stroke and lung fibrosis AI imaging tool provider, has announced a £4.8m funding extension to expand its operations in the US.

Asia-Pacific markets were mixed on Monday as escalating conflict in Iran rattled travel stocks and pushed oil prices sharply ...

BACKGROUND: There is limited evidence of the relationship between aortic and iliac calcification and aortic events (aortic dissection or aneurysm rupture) and major adverse limb events (MALEs; ...

CereVasc says a new study showed 95% of participants clinically improved through 90 days of follow-up with the company's ...

LeMaitre Vascular (NASDAQ:LMAT) management highlighted fourth-quarter and full-year 2025 operating leverage, strong ...